What are the functional roles of FBXL4 and RSRC1 upregulation in MDD pathogenesis?

OPEN

While FBXL4 and RSRC1 are upregulated in MDD brains, their specific contributions to disease mechanisms are unexplained. FBXL4 is involved in mitochondrial function and RSRC1 in RNA processing, but how their dysregulation leads to depressive phenotypes requires elucidation. Gap type: unexplained_observation Source paper: Common variants on 6q16.2, 12q24.31 and 16p13.3 are associated with major depressive disorder. (2019, Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, PMID:29728651)

Priority: 0.76 Domain: psychiatric-neurobiology Hypotheses: 0
📊 Landscape Analysis

Landscape Summary: What are the functional roles of FBXL4 and RSRC1 upregulation in MDD pathogenesis? is a 0.76 priority gap in psychiatric-neurobiology. It has 0 linked hypotheses with average composite score 0.000. Status: open.

Key Unanswered Questions

Key Researchers

Colonna, Sevlever, et al. (TREM2 biology)

Clinical Trials

What are the functional roles of FBXL4 and RSRC1 upregulation in MDD pathogenesis? — INVOKE-2 (completed)

📈 Living Dashboards
0
Hypotheses
0.000
Top Score
0.000
Avg Score
0
Debates
0.00
Avg Quality
0%
Resolution
0
Mechanistic Families
Gap Resolution Progress0%

Hypothesis Score Distribution

🏆 Competing Hypotheses (Ranked by Score)

No hypotheses linked to this gap yet.

🌊 Knowledge Graph Connections

associated with (2)

RS6686529MDDKCNK2MDD

has unique genetic components separate from (1)

37849304MDD
🕑 Activity Feed

No activity recorded yet.

💬 Discussion

No discussions yet. Be the first to comment.

📋 Investigation Sub-Tasks

Create sub-tasks to investigate specific aspects of this gap:

  • Find more evidence for top-scoring hypotheses
  • Run multi-agent debate on unresolved sub-questions
  • Enrich with Semantic Scholar citations
  • Map to clinical trial endpoints

← Back to All Gaps